Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis.
Curry N, Davenport R, Thomas H, Fox E, Lucas J, Evans A, Massou E, Sharma R, Shanmugaranjan S, Rourke C, Newton A, Deary A, Dallas N, Fitzpatrick-Creamer C, Podbielski JM, Wade CE, Edwards A, Benger J, Morris S, Cotton BA, Piercy J, Green L, Brohi K, Stanworth S. Curry N, et al. Among authors: shanmugaranjan s. Health Technol Assess. 2024 Nov;28(76):1-69. doi: 10.3310/JYTR6938. Health Technol Assess. 2024. PMID: 39545850 Free PMC article. Clinical Trial.
Influence of surgeon learning on outcomes in new ophthalmic procedures: quantified nationwide evidence in endothelial corneal transplantation.
Shanmugaranjan S, Hopkinson C, Downward L, Larkin DFP; National Health Service Blood and Transplant Ocular Tissue Advisory Group and contributing ophthalmologists (OTAG study 33). Shanmugaranjan S, et al. Br J Ophthalmol. 2024 Oct 26:bjo-2024-325366. doi: 10.1136/bjo-2024-325366. Online ahead of print. Br J Ophthalmol. 2024. PMID: 39461734
Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury: The CRYOSTAT-2 Randomized Clinical Trial.
Davenport R, Curry N, Fox EE, Thomas H, Lucas J, Evans A, Shanmugaranjan S, Sharma R, Deary A, Edwards A, Green L, Wade CE, Benger JR, Cotton BA, Stanworth SJ, Brohi K; CRYOSTAT-2 Principal Investigators. Davenport R, et al. Among authors: shanmugaranjan s. JAMA. 2023 Nov 21;330(19):1882-1891. doi: 10.1001/jama.2023.21019. JAMA. 2023. PMID: 37824155 Free PMC article.
6 The impact of COVID-19 on corneal transplantation in England.
Paulus U, Ushiro-Lumb I, Hopkinson C, Downward L, Shanmugaranjan S. Paulus U, et al. Among authors: shanmugaranjan s. BMJ Open Ophthalmol. 2022 Nov;7(Suppl 2):A3. doi: 10.1136/bmjophth-2022-EEBA.6. BMJ Open Ophthalmol. 2022. PMID: 37282687 Free PMC article.
UK audit of the management of major bleeding and time taken to deliver blood products.
Green L, Brohi K, Allen E, Grant-Casey J, Doughty H, Estcourt L, Hearnshaw S, Klein A, Shanmugaranjan S, Phillips S, Hopkinson C. Green L, et al. Among authors: shanmugaranjan s. Br J Anaesth. 2022 Nov;129(5):e111-e114. doi: 10.1016/j.bja.2022.07.036. Epub 2022 Aug 26. Br J Anaesth. 2022. PMID: 36031419 Free article. No abstract available.
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Writing Committee for the REMAP-CAP Investigators; Estcourt LJ, Turgeon AF, McQuilten ZK, McVerry BJ, Al-Beidh F, Annane D, Arabi YM, Arnold DM, Beane A, Bégin P, van Bentum-Puijk W, Berry LR, Bhimani Z, Birchall JE, Bonten MJM, Bradbury CA, Brunkhorst FM, Buxton M, Callum JL, Chassé M, Cheng AC, Cove ME, Daly J, Derde L, Detry MA, De Jong M, Evans A, Fergusson DA, Fish M, Fitzgerald M, Foley C, Goossens H, Gordon AC, Gosbell IB, Green C, Haniffa R, Harvala H, Higgins AM, Hills TE, Hoad VC, Horvat C, Huang DT, Hudson CL, Ichihara N, Laing E, Lamikanra AA, Lamontagne F, Lawler PR, Linstrum K, Litton E, Lorenzi E, MacLennan S, Marshall J, McAuley DF, McDyer JF, McGlothlin A, McGuinness S, Miflin G, Montgomery S, Mouncey PR, Murthy S, Nichol A, Parke R, Parker JC, Priddee N, Purcell DFJ, Reyes LF, Richardson P, Robitaille N, Rowan KM, Rynne J, Saito H, Santos M, Saunders CT, Serpa Neto A, Seymour CW, Silversides JA, Tinmouth AA, Triulzi DJ, Turner AM, van de Veerdonk F, Walsh TS, Wood EM, Berry S, Lewis RJ, Menon DK, McArthur C, Zarychanski R, Angus DC, Webb SA, Roberts DJ, Shankar-Hari M. Writing Committee for the REMAP-CAP Investigators, et al. JAMA. 2021 Nov 2;326(17):1690-1702. doi: 10.1001/jama.2021.18178. JAMA. 2021. PMID: 34606578 Free PMC article. Clinical Trial.